Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Active Biotech AB (publ) (ST: ACTI)

 
ACTI Technical Analysis
5
As on 9th Jun 2023 ACTI STOCK Price closed @ 0.93 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.14 & Strong Sell for SHORT-TERM with Stoploss of 1.14 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ACTISTOCK Price

Open 0.96 Change Price %
High 0.96 1 Day -0.03 -3.12
Low 0.89 1 Week 0.10 12.05
Close 0.93 1 Month 0.10 12.05
Volume 130705 1 Year -0.29 -23.77
52 Week High 1.50 | 52 Week Low 0.58
 
ST Sweden Most Active Stocks
QUIA 0.02 0.00%
QLIFE 0.04 0.00%
SBB-B 5.38 3.07%
STRLNG 0.12 33.33%
LUNE 21.97 6.65%
SAS 0.36 5.88%
URBIT 0.02 0.00%
IDOGEN 0.15 -31.82%
STAR-B 0.89 -1.11%
TELIA 24.60 0.41%
 
ST Sweden Top Gainers Stocks
S2M 0.52 100.00%
NETM-B 1.35 42.11%
STRLNG 0.12 33.33%
IVACC 7.26 32.97%
SPRINT 0.63 16.67%
TH1NG 1.61 16.67%
ATIC 5.14 15.77%
ATIC 5.14 15.77%
CIRCHE 3.69 15.67%
AXIC-A 8.16 15.25%
 
ST Sweden Top Losers Stocks
IDOGEN 0.15 -31.82%
IMMU 0.72 -27.27%
ALLR 1.55 -26.54%
MIDW-A 24.80 -22.98%
KILI 0.76 -16.48%
FRACTL 36.80 -14.02%
DIVIO-B 0.13 -13.33%
ZZ-B 41.50 -12.08%
LIPI 1.49 -11.83%
BACTI-B 72.70 -10.69%
 
 
ACTI
Daily Charts		 ACTI
Intraday Charts		 Whats New @
Bazaartrend		 ACTI
Free Analysis
 
ACTI Important Levels Intraday
RESISTANCE1.06
RESISTANCE1.02
RESISTANCE0.99
RESISTANCE0.97
SUPPORT0.89
SUPPORT0.87
SUPPORT0.84
SUPPORT0.80
 
ACTI Forecast May 2024
Share
4th UP Forecast1.59
3rd UP Forecast1.38
2nd UP Forecast1.25
1st UP Forecast1.12
1st DOWN Forecast0.74
2nd DOWN Forecast0.61
3rd DOWN Forecast0.48
4th DOWN Forecast0.27
 
ACTI Weekly Forecast
4th UP Forecast1.20
3rd UP Forecast1.11
2nd UP Forecast1.06
1st UP Forecast1.01
1st DOWN Forecast0.85
2nd DOWN Forecast0.80
3rd DOWN Forecast0.75
4th DOWN Forecast0.66
 
ACTI Forecast2024
4th UP Forecast2.82
3rd UP Forecast2.21
2nd UP Forecast1.84
1st UP Forecast1.46
1st DOWN Forecast0.4
2nd DOWN Forecast0.02
3rd DOWN Forecast-0.35
4th DOWN Forecast-0.96
 
 
ACTI Other Details
Segment EQ
Market Capital 280747936.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ACTI Address
ACTI
 
ACTI Latest News
 
Your Comments and Response on Active Biotech AB (publ)
 
ACTI Business Profile
Active Biotech AB (publ), a biotechnology company, develops pharmaceutical products the treatment of oncology and immunology diseases in Sweden. The company is developing Naptumomab, an anti-cancer immunotherapy that is in Phase Ib/II clinical trial to treat patients with advanced solid tumors; and Tasquinimod, a small molecule immuno-modulator, which is in Phase Ib/IIa clinical trial for the treatment of relapsed or refractory multiple myeloma. It is also developing Laquinimod, a small molecule immuno-modulator to treat inflammatory eye disorders, non-infectious uveitis, and wet age-related macular degeneration (wAMD). The company has a licensing agreement with NeoTX Therapeutics Ltd. for the development and commercialization of Naptumomab for cancer immunotherapy. Active Biotech AB (publ) was incorporated in 1982 and is headquartered in Lund, Sweden. Address: ScheelevAegen 22, Lund, Sweden, 223 63
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service